Glipconz-30
General Range

Glipconz-30

Plena Remedies Pvt. Ltd.Solan, Himachal Pradesh

Price on request/100 · MOQ 100 boxes

Glipconz-30 Tablets by Plena Remedies contain Gliclazide 30 mg, a prolonged-release oral antidiabetic medicine prescribed for the management of Type 2 Diabetes Mellitus in adults.

Gliclazide belongs to the sulfonylurea class of antidiabetic medicines. It works by stimulating pancreatic beta cells to release insulin, helping lower elevated blood glucose levels. Its prolonged-release formulation is designed to release the medicine gradually over time, supporting sustained blood sugar control.

Glipconz-30 Tablets may be prescribed when diet, exercise and lifestyle modifications alone are insufficient to maintain appropriate blood glucose levels. Depending on the patient's condition, the medicine may be used alone or alongside other prescribed antidiabetic treatments.

Regular blood glucose monitoring, appropriate meal planning and adherence to the prescribed treatment schedule are important during therapy.

Glipconz-30 Tablets should be taken strictly according to a registered medical practitioner's prescription. Dosage adjustments depend on blood glucose levels, kidney function, medical history and treatment response.

CategoryGeneral Range
Min. Order100 boxes
Supplied byPlena Remedies Pvt. Ltd.
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Gliclazide Prolonged-release Tablets IP 30 mg
Packaging Type
Tablets
Packaging Size
30 mg
Dosage Form
Tablet
Treatment
Helps improve blood glucose levels when used alongside an appropriate diet and exercise plan.
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Plena Remedies Pvt. Ltd.Solan, Himachal Pradesh
View Full Profile

Plena Remedies Pvt. Ltd. is an Indian pharmaceutical and healthcare company.

Key Details

• Incorporation / Establishment: Incorporated on August 22, 2023 (registered under corporate entities as Plena Remedies Private Limited in Himachal Pradesh), with brand origins dating back earlier.
• Registered Office / Location: Plot No. 17, Himuda Ind. Area, Bhatoli Kalan, Baddi, Solan, Himachal Pradesh, 173201, India.
• Leadership / Directors: Munesh Kumar (CEO / Director) and Vijay Singh.
• Certifications: ISO 9001:2015, WHO-GMP, and GLP certified.
• Core Business & Services:
• PCD Pharma Franchise: Offers monopoly-based franchise opportunities across India.
• Third-Party / Contract Manufacturing: Produces bulk formulations for other brands.
• Product Portfolio: 1,500+ certified formulations spanning tablets, capsules, injectables, syrups, dry syrups, ointments, and specialized divisions like pediatric, orthopedic, gynecology, dermatology, cardiology, and nutraceuticals.
• Ecosystem Partners: Associated with sister or collaborative entities like Itelic Labs and Rajora Biotech.

More General Range